Dashboard
Manage Tickers

KALAKALA BIO, Inc.

Nasdaq kalarx.com


$ 6.22 $ -0.06 (-0.96 %)    

Friday, 16-Aug-2024 14:41:12 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 480.15 $ -1.01 (-0.21 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.91 (-0.16 %)
TLT $ 98.68 $ 0.78 (0.8 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 6.22
$ 5.90 x 250
-- x --
-- - --
$ 4.21 - $ 14.50
3,412
na
18.85M
$ 0.21
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-29-2024 12-31-2023 10-K
4 11-13-2023 09-30-2023 10-Q
5 08-04-2023 06-30-2023 10-Q
6 05-09-2023 03-31-2023 10-Q
7 03-03-2023 12-31-2022 10-K
8 11-08-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-16-2022 03-31-2022 10-Q
11 03-29-2022 12-31-2021 10-K
12 11-15-2021 09-30-2021 10-Q
13 08-05-2021 06-30-2021 10-Q
14 05-05-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 11-05-2020 09-30-2020 10-Q
17 08-06-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-12-2020 12-31-2019 10-K
20 11-07-2019 09-30-2019 10-Q
21 08-06-2019 06-30-2019 10-Q
22 05-09-2019 03-31-2019 10-Q
23 03-12-2019 12-31-2018 10-K
24 11-08-2018 09-30-2018 10-Q
25 08-09-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 04-02-2018 12-31-2017 10-K
28 11-07-2017 09-30-2017 10-Q
29 08-31-2017 06-30-2017 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

oppenheimer-reiterates-outperform-on-kala-bio-maintains-15-price-target
Oppenheimer Reiterates Outperform on Kala ...
08/19/2024 14:46:57

Oppenheimer analyst Francois Brisebois reiterates Kala Bio (NASDAQ:KALA) with a Outperform and maintains $15 price target.

kala-bio-q2-eps-316-beats-440-estimate
Kala Bio Q2 EPS $(3.16) Beats $(4.40) Esti...
08/06/2024 12:02:30

Kala Bio (NASDAQ:KALA) reported quarterly losses of $(3.16) per share which beat the analyst consensus estimate of $(4.40) by 2...

correction-kala-bio-files-for-shelf-of-up-to-3519m-shares-by-selling-shareholders
CORRECTION: KALA BIO Files For Shelf Of Up...
07/25/2024 20:38:05

kala-bio-announces-a-125m-private-placement
KALA BIO Announces A $12.5M Private Placement
06/27/2024 12:01:12

hc-wainwright--co-maintains-buy-on-kala-bio-lowers-price-target-to-18
HC Wainwright & Co. Maintains Buy on Kala ...
05/17/2024 14:46:52

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $21 to ...

kala-pharmaceuticals-q1-2024-adj-eps-420-misses-289-estimate
Kala Pharmaceuticals Q1 2024 Adj EPS $(4.2...
05/14/2024 20:28:21

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(4.20) per share which missed the analyst consensus estimate o...

hc-wainwright--co-maintains-buy-on-kala-bio-lowers-price-target-to-21
HC Wainwright & Co. Maintains Buy on Kala ...
04/02/2024 15:47:15

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $22 to ...

oppenheimer-reiterates-outperform-on-kala-bio-maintains-15-price-target
Oppenheimer Reiterates Outperform on Kala ...
04/01/2024 13:23:19

Oppenheimer analyst Francois Brisebois reiterates Kala Bio (NASDAQ:KALA) with a Outperform and maintains $15 price target.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
12/05/2023 17:31:07

hc-wainwright--co-maintains-buy-on-kala-bio-lowers-price-target-to-22
HC Wainwright & Co. Maintains Buy on Kala ...
11/17/2023 11:49:38

HC Wainwright & Co. analyst Yi Chen maintains Kala Bio (NASDAQ:KALA) with a Buy and lowers the price target from $24 to ...

kala-bio-q3-earnings-insights
Kala Bio: Q3 Earnings Insights
11/13/2023 13:30:13

kala-pharmaceuticals-q3-eps-341-misses-215-estimate
Kala Pharmaceuticals Q3 EPS $(3.41) Misses...
11/13/2023 13:11:42

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(3.41) per share which missed the analyst consensus estimate o...

hc-wainwright--co-reiterates-buy-on-kala-bio-maintains-24-price-target
HC Wainwright & Co. Reiterates Buy on Kala...
08/11/2023 17:11:23

HC Wainwright & Co. analyst Yi Chen reiterates Kala Bio (NASDAQ:KALA) with a Buy and maintains $24 price target.

kala-pharmaceuticals-q2-eps-436-up-from-1892-yoy-592m-in-cash-cash-equivalents-and-short-term-expected-to-fund-operations-into-2q-2025
Kala Pharmaceuticals Q2 EPS $(4.36) Up Fro...
08/04/2023 12:03:50

Kala Pharmaceuticals (NASDAQ:KALA) reported quarterly losses of $(4.36) per share. This is a 76.96 percent increase over losses...

kala-pharmaceuticals-announces-name-change-to-kala-bio-effective-august-2-2023
Kala Pharmaceuticals Announces Name Change...
08/02/2023 12:11:24

Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and...

10-short-squeeze-stocks-to-watch-aeglea-biotherapeutics-toro-corp-airsculpt-a-company-moves-up-4166-positions--more
10 Short Squeeze Stocks To Watch: Aeglea B...
07/24/2023 18:05:39

Potential short squeeze plays gained steam in 2021, continued throughout 2022, and remain a focus of new traders looking for th...

kala-pharmaceuticals-13g-filing-shows-checkpoint-capital-master-fund-lp-increased-stake-in-co-to-97
Kala Pharmaceuticals 13G Filing Shows Chec...
06/15/2023 16:11:39

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
06/02/2023 17:31:42

10-short-squeeze-stocks-to-watch-toro-corp-paxmedica-getty-images-and-more
10 Short Squeeze Stocks To Watch: Toro Cor...
05/15/2023 15:37:55

Potential short squeeze plays gained steam in 2021, continued through 2022, and remain a focus of new traders looking for the n...

hc-wainwright--co-reiterates-buy-on-kala-pharmaceuticals-raises-price-target-to-24
HC Wainwright & Co. Reiterates Buy on Kala...
05/10/2023 10:44:35

HC Wainwright & Co. analyst Yi Chen reiterates Kala Pharmaceuticals (NASDAQ:KALA) with a Buy and raises the price target...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION